Cargando…

The prognosis of patients hospitalized with a first episode of heart failure, validation of two scores: PREDICE and AHEAD

PURPOSE: Heart failure (HF) is a chronic, frequent and disabling condition but with a modifiable course and a large potential for improving. The aim of this study was to validate the two available clinical prediction rules for mortality at one year in patients with primo-hospitalization for decompen...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruiz-Ruiz, Francisco, Menéndez-Orenga, Miguel, Medrano, Francisco J, Calderón, Enrique J, Lora-Pablos, David, Navarro-Puerto, Maria Asunción, Rodríguez-Torres, Patricia, Gómez de la Cámara, Agustín
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660629/
https://www.ncbi.nlm.nih.gov/pubmed/31413639
http://dx.doi.org/10.2147/CLEP.S206017
_version_ 1783439337256386560
author Ruiz-Ruiz, Francisco
Menéndez-Orenga, Miguel
Medrano, Francisco J
Calderón, Enrique J
Lora-Pablos, David
Navarro-Puerto, Maria Asunción
Rodríguez-Torres, Patricia
Gómez de la Cámara, Agustín
author_facet Ruiz-Ruiz, Francisco
Menéndez-Orenga, Miguel
Medrano, Francisco J
Calderón, Enrique J
Lora-Pablos, David
Navarro-Puerto, Maria Asunción
Rodríguez-Torres, Patricia
Gómez de la Cámara, Agustín
author_sort Ruiz-Ruiz, Francisco
collection PubMed
description PURPOSE: Heart failure (HF) is a chronic, frequent and disabling condition but with a modifiable course and a large potential for improving. The aim of this study was to validate the two available clinical prediction rules for mortality at one year in patients with primo-hospitalization for decompensated HF: PREDICE and AHEAD. The secondary aim was to evaluate in our setting the changes in the clinical pattern of HF in the last decade in patients hospitalized for a first episode of the disease. PATIENTS AND METHODS: A prospective multicenter cohort study, which included 180 patients hospitalized with “de novo” HF was conducted to validate the PREDICE score. Calibration and discrimination measurements were calculated for the PREDICE model and the PREDICE score (using the validation cohort of the PREDICE) and the AHEAD score (using both the development and the validation cohort of the PREDICE). RESULTS: For the PREDICE models, the area under the curve (AUC) was 0.68 (95% confidence interval [CI]: 0.57–0.79) and the calibration slope 0.65 (95% CI: 0.21–1.20). For the PREDICE score AUC was 0.59 (95% CI: 0.47–0.71) and slope 0.42 (95% CI: −0.20–1.17). For the AHEAD score the AUC was 0.68 (95% CI: 0.62–0.73) and slope 1.38 (95% CI: 0.62–0.73) when used the development cohort of PREDICE and the AUC was 0.58 (95% CI: 0.49–0.67), and slope 0.68 (95% CI: −0.06 to 1.47) when used its validation cohort. CONCLUSION: The present study shows that the two risk scores available for patients with primo-hospitalization for decompensated HF (PREDICE and AHEAD) are not currently valid for predicting mortality at one-year. In our setting the clinical spectrum of hospitalized patients with new-onset HF has been modified over time. The study underscores the need to validate the prognostic models before clinical implementation.
format Online
Article
Text
id pubmed-6660629
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-66606292019-08-14 The prognosis of patients hospitalized with a first episode of heart failure, validation of two scores: PREDICE and AHEAD Ruiz-Ruiz, Francisco Menéndez-Orenga, Miguel Medrano, Francisco J Calderón, Enrique J Lora-Pablos, David Navarro-Puerto, Maria Asunción Rodríguez-Torres, Patricia Gómez de la Cámara, Agustín Clin Epidemiol Original Research PURPOSE: Heart failure (HF) is a chronic, frequent and disabling condition but with a modifiable course and a large potential for improving. The aim of this study was to validate the two available clinical prediction rules for mortality at one year in patients with primo-hospitalization for decompensated HF: PREDICE and AHEAD. The secondary aim was to evaluate in our setting the changes in the clinical pattern of HF in the last decade in patients hospitalized for a first episode of the disease. PATIENTS AND METHODS: A prospective multicenter cohort study, which included 180 patients hospitalized with “de novo” HF was conducted to validate the PREDICE score. Calibration and discrimination measurements were calculated for the PREDICE model and the PREDICE score (using the validation cohort of the PREDICE) and the AHEAD score (using both the development and the validation cohort of the PREDICE). RESULTS: For the PREDICE models, the area under the curve (AUC) was 0.68 (95% confidence interval [CI]: 0.57–0.79) and the calibration slope 0.65 (95% CI: 0.21–1.20). For the PREDICE score AUC was 0.59 (95% CI: 0.47–0.71) and slope 0.42 (95% CI: −0.20–1.17). For the AHEAD score the AUC was 0.68 (95% CI: 0.62–0.73) and slope 1.38 (95% CI: 0.62–0.73) when used the development cohort of PREDICE and the AUC was 0.58 (95% CI: 0.49–0.67), and slope 0.68 (95% CI: −0.06 to 1.47) when used its validation cohort. CONCLUSION: The present study shows that the two risk scores available for patients with primo-hospitalization for decompensated HF (PREDICE and AHEAD) are not currently valid for predicting mortality at one-year. In our setting the clinical spectrum of hospitalized patients with new-onset HF has been modified over time. The study underscores the need to validate the prognostic models before clinical implementation. Dove 2019-07-22 /pmc/articles/PMC6660629/ /pubmed/31413639 http://dx.doi.org/10.2147/CLEP.S206017 Text en © 2019 Ruiz-Ruiz et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Ruiz-Ruiz, Francisco
Menéndez-Orenga, Miguel
Medrano, Francisco J
Calderón, Enrique J
Lora-Pablos, David
Navarro-Puerto, Maria Asunción
Rodríguez-Torres, Patricia
Gómez de la Cámara, Agustín
The prognosis of patients hospitalized with a first episode of heart failure, validation of two scores: PREDICE and AHEAD
title The prognosis of patients hospitalized with a first episode of heart failure, validation of two scores: PREDICE and AHEAD
title_full The prognosis of patients hospitalized with a first episode of heart failure, validation of two scores: PREDICE and AHEAD
title_fullStr The prognosis of patients hospitalized with a first episode of heart failure, validation of two scores: PREDICE and AHEAD
title_full_unstemmed The prognosis of patients hospitalized with a first episode of heart failure, validation of two scores: PREDICE and AHEAD
title_short The prognosis of patients hospitalized with a first episode of heart failure, validation of two scores: PREDICE and AHEAD
title_sort prognosis of patients hospitalized with a first episode of heart failure, validation of two scores: predice and ahead
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660629/
https://www.ncbi.nlm.nih.gov/pubmed/31413639
http://dx.doi.org/10.2147/CLEP.S206017
work_keys_str_mv AT ruizruizfrancisco theprognosisofpatientshospitalizedwithafirstepisodeofheartfailurevalidationoftwoscoresprediceandahead
AT menendezorengamiguel theprognosisofpatientshospitalizedwithafirstepisodeofheartfailurevalidationoftwoscoresprediceandahead
AT medranofranciscoj theprognosisofpatientshospitalizedwithafirstepisodeofheartfailurevalidationoftwoscoresprediceandahead
AT calderonenriquej theprognosisofpatientshospitalizedwithafirstepisodeofheartfailurevalidationoftwoscoresprediceandahead
AT lorapablosdavid theprognosisofpatientshospitalizedwithafirstepisodeofheartfailurevalidationoftwoscoresprediceandahead
AT navarropuertomariaasuncion theprognosisofpatientshospitalizedwithafirstepisodeofheartfailurevalidationoftwoscoresprediceandahead
AT rodrigueztorrespatricia theprognosisofpatientshospitalizedwithafirstepisodeofheartfailurevalidationoftwoscoresprediceandahead
AT gomezdelacamaraagustin theprognosisofpatientshospitalizedwithafirstepisodeofheartfailurevalidationoftwoscoresprediceandahead
AT ruizruizfrancisco prognosisofpatientshospitalizedwithafirstepisodeofheartfailurevalidationoftwoscoresprediceandahead
AT menendezorengamiguel prognosisofpatientshospitalizedwithafirstepisodeofheartfailurevalidationoftwoscoresprediceandahead
AT medranofranciscoj prognosisofpatientshospitalizedwithafirstepisodeofheartfailurevalidationoftwoscoresprediceandahead
AT calderonenriquej prognosisofpatientshospitalizedwithafirstepisodeofheartfailurevalidationoftwoscoresprediceandahead
AT lorapablosdavid prognosisofpatientshospitalizedwithafirstepisodeofheartfailurevalidationoftwoscoresprediceandahead
AT navarropuertomariaasuncion prognosisofpatientshospitalizedwithafirstepisodeofheartfailurevalidationoftwoscoresprediceandahead
AT rodrigueztorrespatricia prognosisofpatientshospitalizedwithafirstepisodeofheartfailurevalidationoftwoscoresprediceandahead
AT gomezdelacamaraagustin prognosisofpatientshospitalizedwithafirstepisodeofheartfailurevalidationoftwoscoresprediceandahead